rs3736963

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_025179.4(PLXNA2):​c.4863C>T​(p.Tyr1621Tyr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.554 in 1,602,934 control chromosomes in the GnomAD database, including 251,313 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23647 hom., cov: 32)
Exomes 𝑓: 0.55 ( 227666 hom. )

Consequence

PLXNA2
NM_025179.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0007056
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.867
Variant links:
Genes affected
PLXNA2 (HGNC:9100): (plexin A2) This gene encodes a member of the plexin-A family of semaphorin co-receptors. Semaphorins are a large family of secreted or membrane-bound proteins that mediate repulsive effects on axon pathfinding during nervous system development. A subset of semaphorins are recognized by plexin-A/neuropilin transmembrane receptor complexes, triggering a cellular signal transduction cascade that leads to axon repulsion. This plexin-A family member is thought to transduce signals from semaphorin-3A and -3C. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-208034494-G-A is Benign according to our data. Variant chr1-208034494-G-A is described in ClinVar as [Benign]. Clinvar id is 1164720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.867 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.588 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLXNA2NM_025179.4 linkuse as main transcriptc.4863C>T p.Tyr1621Tyr splice_region_variant, synonymous_variant 27/32 ENST00000367033.4 NP_079455.3 O75051-1
PLXNA2XM_005273164.4 linkuse as main transcriptc.4908C>T p.Tyr1636Tyr splice_region_variant, synonymous_variant 27/33 XP_005273221.1
PLXNA2XM_005273165.5 linkuse as main transcriptc.4908C>T p.Tyr1636Tyr splice_region_variant, synonymous_variant 27/31 XP_005273222.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLXNA2ENST00000367033.4 linkuse as main transcriptc.4863C>T p.Tyr1621Tyr splice_region_variant, synonymous_variant 27/321 NM_025179.4 ENSP00000356000.3 O75051-1

Frequencies

GnomAD3 genomes
AF:
0.552
AC:
83827
AN:
151944
Hom.:
23643
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.557
Gnomad AMI
AF:
0.598
Gnomad AMR
AF:
0.506
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.251
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.584
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.593
Gnomad OTH
AF:
0.558
GnomAD3 exomes
AF:
0.507
AC:
127438
AN:
251200
Hom.:
34058
AF XY:
0.504
AC XY:
68437
AN XY:
135770
show subpopulations
Gnomad AFR exome
AF:
0.554
Gnomad AMR exome
AF:
0.434
Gnomad ASJ exome
AF:
0.517
Gnomad EAS exome
AF:
0.253
Gnomad SAS exome
AF:
0.348
Gnomad FIN exome
AF:
0.594
Gnomad NFE exome
AF:
0.588
Gnomad OTH exome
AF:
0.540
GnomAD4 exome
AF:
0.554
AC:
803752
AN:
1450874
Hom.:
227666
Cov.:
29
AF XY:
0.549
AC XY:
396454
AN XY:
722364
show subpopulations
Gnomad4 AFR exome
AF:
0.560
Gnomad4 AMR exome
AF:
0.437
Gnomad4 ASJ exome
AF:
0.518
Gnomad4 EAS exome
AF:
0.273
Gnomad4 SAS exome
AF:
0.350
Gnomad4 FIN exome
AF:
0.591
Gnomad4 NFE exome
AF:
0.584
Gnomad4 OTH exome
AF:
0.541
GnomAD4 genome
AF:
0.552
AC:
83867
AN:
152060
Hom.:
23647
Cov.:
32
AF XY:
0.545
AC XY:
40480
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.557
Gnomad4 AMR
AF:
0.505
Gnomad4 ASJ
AF:
0.510
Gnomad4 EAS
AF:
0.252
Gnomad4 SAS
AF:
0.343
Gnomad4 FIN
AF:
0.584
Gnomad4 NFE
AF:
0.593
Gnomad4 OTH
AF:
0.552
Alfa
AF:
0.572
Hom.:
55043
Bravo
AF:
0.547
Asia WGS
AF:
0.305
AC:
1066
AN:
3478
EpiCase
AF:
0.587
EpiControl
AF:
0.584

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
PLXNA2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 11, 2022This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
3.1
DANN
Benign
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00071
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3736963; hg19: chr1-208207839; COSMIC: COSV65438328; COSMIC: COSV65438328; API